Ohe, C.; Yoshida, T.; Ikeda, J.; Tsuzuki, T.; Ohashi, R.; Ohsugi, H.; Atsumi, N.; Yamaka, R.; Saito, R.; Yasukochi, Y.;
et al. Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes. Biomedicines 2022, 10, 323.
https://doi.org/10.3390/biomedicines10020323
AMA Style
Ohe C, Yoshida T, Ikeda J, Tsuzuki T, Ohashi R, Ohsugi H, Atsumi N, Yamaka R, Saito R, Yasukochi Y,
et al. Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes. Biomedicines. 2022; 10(2):323.
https://doi.org/10.3390/biomedicines10020323
Chicago/Turabian Style
Ohe, Chisato, Takashi Yoshida, Junichi Ikeda, Toyonori Tsuzuki, Riuko Ohashi, Haruyuki Ohsugi, Naho Atsumi, Ryosuke Yamaka, Ryoichi Saito, Yoshiki Yasukochi,
and et al. 2022. "Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes" Biomedicines 10, no. 2: 323.
https://doi.org/10.3390/biomedicines10020323
APA Style
Ohe, C., Yoshida, T., Ikeda, J., Tsuzuki, T., Ohashi, R., Ohsugi, H., Atsumi, N., Yamaka, R., Saito, R., Yasukochi, Y., Higasa, K., Kinoshita, H., & Tsuta, K.
(2022). Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes. Biomedicines, 10(2), 323.
https://doi.org/10.3390/biomedicines10020323